Tranexamic acid

(Mfr: SAA)(Conc: 100 mg/mL)

Blinatumomab

(Mfr: AMG)(Conc: 0.375 mcg/mL^b)

Remarks:

Persistent particulate formation when blinatumomab is added to tranexamic acid; not observed when order of mixing was reversed

Ref:

³⁴⁰⁵,³⁴¹⁷